In an interview with Pharmacy Times, City of Hope researchers discuss a preclinical platform designed to redirect CAR T cells after infusion and how pharmacists could help bring this adaptable approach into clinical practice.
|Articles|January 13, 2022
Clinical Pearl of the Day: Germ Cell Tumors
Author(s)Saro Arakelians, PharmD
Germ cell tumors that occur in places other than the testicles and ovaries are very rare.
Advertisement
Clinical Pearl of the Day: Germ Cell Tumors
Germ cell tumors are growths of cells that form from reproductive cells.
Insight:
- Germ cell tumors may or may not be cancerous. Most germ cell tumors occur in the testicles or the ovaries.
- Some germ cell tumors occur in other areas of the body, such as the abdomen, brain and chest, though it's not clear why.
- Germ cell tumors that occur in places other than the testicles and ovaries (extragonadal germ cell tumors) are very rare.
- Treatment options for germ cell tumors may include surgery to remove the tumor, chemotherapy with drugs that kill cancer cells, and radiation therapy with powerful energy beams.
- The drugs that are commonly used for treating germ cell tumors include bleomycin (available as a generic drug), cisplatin (available as a generic drug), etoposide (Etopophos), and ifosfamide (Ifex).
- Support: Physical and emotional support is another treatment option that may be needed for these patients.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
Investigational inhaled stem cells for COPD raise questions about lasting clinical benefit and the pharmacy controls needed to deliver a living-cell product through a nebulizer.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague and which antibiotics the CDC recommends.
In an interview with Pharmacy Times, Abdulkader Rahmo, PhD, discusses investigational inhaled cell therapy for COPD, the evidence needed to establish lasting clinical benefit, and pharmacists’ potential role in its delivery.
Pharmacists can explain the evidence supporting the intramuscular injection, address specific concerns, and help families understand what is known—and what is not known—about oral vitamin K.
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
Advertisement
Advertisement